久久精品国产亚洲夜色av网站,久久人人爽人人爽人人片dvd,久久久久人妻一区精品色,

hexadecanol;
1-Cetanol;
Adol 52;
Adol 52NF;
Adol 54;
Alfol 16;
Alfol 16RD;
Atalco C;
CO 1695;
CO 1695F;
Cachalot C 51;
Cetaffine;
Cetal;
Cetalcos;
Cetalol CA;
Cetanol;
Cetyl AlcoholNX;
Cetyl alcohol;
Cetylic alcohol;
Cetylol;
Conol 1695;
Crodacol C;
Crodacol C95;
Crodacol CAS;
Crodacol CAT;
Elfacos C;
Epal 16;
Ethal;
Ethol;
Hainol 16SS;
Hexadecanol;
Hexadecyl alcohol;
Hyfatol 16;
Hyfatol 16-85;
Hyfatol 16-95;
Kalcohl60;
Kalcohl 6098;
Kalcol 6098;
Kalcol 68;
Lanette 16;
Lanol C;
LAurex 16;
Lipocol C;
Lorol 24;
Lorol C 14/98;
Lorol C 16;
Loxanol K;
Loxanol K extra;
Loxanwax SK;
NAA 44;
NSC 4194;
Nacol 1618;
Palmitic alcohol;
Palmityl alcohol;
Product 308;
Siponol CC;
Siponol Wax A;
Tego Alkanol 16;
n-1-Hexadecanol;
n-Cetyl alcohol;
n-Hexadecanol

C16H34O

詳情

供應(yīng)商

27306-90-7

聚氧乙烯月桂醚羧酸

Polyoxyethylene lauryl ether carboxylic acid;
glycolic acid ethoxylate lauryl ether;
lAureth-4 carboxylic acid,lAureth-5 carboxylic acid,lAureth-11;
lAureth-4carboxylicacid,lAureth-5carboxylicacid,lAureth-11

(C2H4O)nC14H28O3

詳情

供應(yīng)商

646-30-0

十九酸

Nonadecanoic acid;
nonadecylic acid;
NonadecansAure

Aureobasidin I (9CI);
AureobasidinA, 5-L-leucine-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine,cyclic peptide deriv.;
Antibiotic R 106VIII;
Cyclo[L-leucyl-N-methyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, 3-hydroxy-N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-leucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]-

Aureobasidin F (9CI);
AureobasidinA, 6-L-valine-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine,cyclic peptide deriv.;
Antibiotic R 106V;
Cyclo[L-alloisoleucyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, 3-hydroxy-N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]-

Aureobasidin E (9CI);
AureobasidinA, 3-(erythro-b-hydroxy-N-methyl-L-phenylalanine)-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine,cyclic peptide deriv.;
Antibiotic R 106-IV;
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-(bS)-b-hydroxy-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine,3-hydroxy-N-[N-[N-[N-[1-[erythro-b-hydroxy-N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]-;
R 106-4

Aureobasidin G (9CI);
AureobasidinA, 8-(N-methyl-L-valine)-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine,cyclic peptide deriv.;
Antibiotic R 106VI;
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]-

Aureobasidin K (9CI);
AureobasidinA,1-[N-(2-hydroxy-3-methyl-1-oxobutyl)-N-methyl-L-valine]-8-(N-methyl-L-valine)-,(R)-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine,cyclic peptide deriv.;
Antibiotic R 106Xa;
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N-methyl-L-valyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxobutyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, (R)-

Aureobasidin T2 (9CI);
AureobasidinA, 6-(N-methyl-L-leucine)-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine,cyclic peptide deriv.;
Cyclo[L-alloisoleucyl-N-methyl-L-leucyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl]

Aureobasidin D (9CI);
AureobasidinA, 8-(4-hydroxy-N-methyl-L-valine)-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine,cyclic peptide deriv.;
Antibiotic R 106III;
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-4-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, 4-hydroxy-N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone

Aureobasidin Q (9CI);
AureobasidinA, 8-(N-methyl-L-phenylalanine)-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine,cyclic peptide deriv.;
Antibiotic R 106XV;
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N-methyl-L-phenylalanyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];
L-Phenylalanine, N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]-

Aureobasidin T1 (9CI);
AureobasidinA, [R-(R*,S*)]-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine,cyclic peptide deriv.;
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3S)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl]

Aureobasidin B (9CI);
AureobasidinA, 1-[N-(2-hydroxy-3-methyl-1-oxobutyl)-N-methyl-L-valine]-, (R)-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine,cyclic peptide deriv.;
Antibiotic R 106IIa;
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, 3-hydroxy-N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxobutyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, (R)-

Aureobasidin M (9CI);
AureobasidinA, 3-L-phenylalanine-8-(N-methyl-L-valine)-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine, cyclicpeptide deriv.;
Antibiotic R 106XI;
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-L-phenylalanyl-L-prolyl];
L-Valine, N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]-

Ajmalan-17-one,10,10'-methylenebis[19,20-didehydro-11-methoxy-, (19E)-(19'E)- (9CI);
RAureflexine

Aureobasidin T3 (9CI);
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N-methyl-L-valyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl-L-phenylalanyl-b-hydroxy-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, N-[N-[N-[N-[1-[b-hydroxy-N-[N-[N-(2-hydroxy-3-methyl-1-oxobutyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, (R)-

Aureobasidin U1 (9CI);
AureobasidinA, 1-[N-(2-hydroxy-3-methyl-1-oxopentyl)-L-valine]-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine,cyclic peptide deriv.;
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, 3-hydroxy-N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]-

Aureobasidin S1 (9CI);
AureobasidinA, 5-[4-(methylsulfinyl)-L-2-aminobutanoic acid]-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacycloheptacosine,cyclic peptide deriv.;
Cyclo[(2S)-2-amino-4-(methylsulfinyl)butanoyl-N-methyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl-4-(methylsulfinyl)-L-2-aminobutanoyl-N-methyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-,a1-lactone, [R-(R*,R*)]-

C59H90N8O12S

詳情

供應(yīng)商

毛片免费视频观看,久久亚洲国产精品123区,精品无人区麻豆乱码1区2区新区,久久久亚洲av成人网站,久久人人爽人人爽人人av东京热

化工產(chǎn)品